{
    "ASSERTIONS": {
        "id": 700,
        "context": null,
        "description": "CRKL amplification was observed in an EGFR inhibitor resistant tumor after researchers observed that cells from gefitinib-sensitive cell line (HCC827) overexpressing CRKL became resistant to gefitinib relative to controls.",
        "disease": {
            "name": "Non-Small Cell Lung Cancer",
            "oncotree_code": "NSCLC",
            "oncotree_term": "Non-Small Cell Lung Cancer"
        },
        "therapy_name": "Gefitinib",
        "therapy_type": "Targeted therapy",
        "clinical_significance": "resistance",
        "predictive_implication": "Clinical evidence",
        "favorable_prognosis": null,
        "created_on": "03/31/21",
        "last_updated": "2017-11-03",
        "submitted_by": "breardon@broadinstitute.org",
        "validated": true,
        "source_ids": 200,
        "variant": {
            "id": 700,
            "cytoband": "22q11.21",
            "direction": "Amplification",
            "feature_type": "copy_number",
            "gene": "CRKL",
            "feature": "CRKL Amplification"
        }
    },
    "SOURCES": {
        "id": 200,
        "type": "Journal",
        "doi": "10.1158/2159-8290.CD-11-0046",
        "nct": "None",
        "pmid": 22586683,
        "url": "https://doi.org/10.1158/2159-8290.CD-11-0046",
        "citation": "Cheung HW, Du J, Boehm JS, et al. Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers. Cancer Discov. 2011;1(7):608-25."
    },
    "VARIANTS": {
        "id": 700,
        "cytoband": "22q11.21",
        "direction": "Amplification",
        "feature_type": "copy_number",
        "gene": "CRKL",
        "feature": "CRKL Amplification"
    }
}